Pitavastatin increases ABCA1-mediated lipid efflux from Fu5AH rat hepatoma cells

Biochemical and Biophysical Research Communications
Ilaria ZanottiFranco Bernini

Abstract

ATP binding cassette A1 (ABCA1) is responsible in vivo for the formation of HDL by promoting the lipidation of apoprotein A-I (apoA-I) via cholesterol and phospholipid efflux from the liver. Treatment of patients with statins produces an increase in HDL plasma level, but the underlying mechanism is not completely understood. In this work we investigated the ability of pitavastatin to modulate ABCA1-mediated efflux from Fu5AH rat hepatoma cells, that here we demonstrate to express functional ABCA1 upon treatment with 22OH/cRA. In both basal and ABCA1 expressing cells pitavastatin 0.1-50microM induced a dose-dependent increase in cholesterol efflux to apoA-I; this effect was reversed by mevalonate or geranyl geraniol. A stimulatory effect was also observed on phospholipid efflux. Similar results were obtained with compactin, suggesting a class-related effect of statins. These results indicate a potential mechanism for the improvement in HDL plasma profile observed in patients treated with statins.

References

Nov 9, 1989·The New England Journal of Medicine·D J Gordon, B M Rifkind
Dec 25, 1987·JAMA : the Journal of the American Medical Association·J M Hoeg, H B Brewer
Jul 1, 1996·Current Opinion in Cardiology·J KjekshusJ A Tobert
Aug 22, 1997·The Journal of Biological Chemistry·Y JiA R Tall
Jun 5, 1998·JAMA : the Journal of the American Medical Association·R S Rosenson, C C Tangney
May 14, 1999·Arteriosclerosis, Thrombosis, and Vascular Biology·G FranceschiniF Bernini
Jul 14, 2000·The Journal of Biological Chemistry·A E BortnickO L Francone
Jun 8, 2001·The Journal of Clinical Investigation·G MartinB Staels
Oct 20, 2001·The Journal of Biological Chemistry·X GanT Q Cai
Mar 16, 2002·Laboratory Investigation; a Journal of Technical Methods and Pathology·Cheryl L WellingtonMichael R Hayden
Mar 26, 2002·Metabolism: Clinical and Experimental·Tomi S MikkolaRichard W St Clair
Aug 2, 2002·Current Opinion in Lipidology·John F Oram
Sep 19, 2002·Molecular and Cellular Biochemistry·Neelam Srivastava
Oct 3, 2002·Biochemical and Biophysical Research Communications·Edward B NeufeldH Bryan Brewer
Nov 2, 2002·Stroke; a Journal of Cerebral Circulation·Thomas B ClarksonRichard W St Clair
Nov 7, 2002·Circulation Journal : Official Journal of the Japanese Circulation Society·Pang H ChongCory Franklin
Dec 10, 2002·Biochemical and Biophysical Research Communications·Elda FavariLaura Calabresi
Mar 5, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Patricia G YanceyGeorge H Rothblat
Apr 5, 2003·Drug News & Perspectives·John F. Oram
Apr 23, 2003·Molecular Genetics and Metabolism·Maxime DenisJacques Genest
Apr 24, 2003·Clinical Cardiology·James M McKenney
May 24, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Roshni R SingarajaMichael R Hayden
Mar 23, 2004·Biochemical and Biophysical Research Communications·Hirohito SoneNobuhiro Yamada
May 14, 2005·Current Opinion in Lipidology·Miranda Van EckTheo Jc Van Berkel

❮ Previous
Next ❯

Citations

Aug 16, 2011·Journal of Neurology·Matias TrbušićSaša Frank
Jul 22, 2006·Pflügers Archiv : European journal of physiology·Ana ZarubicaGiovanna Chimini
Jun 1, 2005·Biochimica Et Biophysica Acta·Gerd Schmitz, Thomas Langmann
May 21, 2005·Methods : a Companion to Methods in Enzymology·Emma I WaddingtonGordon A Francis
Jan 5, 2010·Cardiovascular Research·Yoko KojimaKen-ichi Hirata
Dec 23, 2009·BMC Cell Biology·Ildikó KaszaLászló Homolya
May 21, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Nicholas F FitzRadosveta Koldamova
Jun 1, 2011·Drug Design, Development and Therapy·Yasuyuki KawaiKouji Kajinami
Jun 18, 2009·Pharmacogenomics·Fabiana D V GenvigirRosario D C Hirata
Sep 24, 2010·Pharmacogenomics·Fabiana Dalla Vecchia GenvigirRosario Dominguez Crespo Hirata
Aug 9, 2006·European Journal of Clinical Investigation·S MwevaN Fournier
Jan 13, 2015·Atherosclerosis. Supplements·Lorenzo Arnaboldi, Alberto Corsini
Sep 17, 2013·Journal of Lipid Research·Koushik RoySyamal Roy
Feb 20, 2019·Cardiovascular Drugs and Therapy·Andrei C SpositoAlan Remaley
Jan 15, 2020·Pharmaceutical Medicine·Dmitry Y LitvinovAlexander D Dergunov
Jul 15, 2005·Vascular Medicine·S SoumianR G J Gibbs

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.